HILLARY CAFFEY: Open Payments
NPI 1942730684 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 6 companies in 2025. Trend: 2023 $300 · 2024 $160 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Novo Nordisk Inc | 4 | $74 |
| Lilly USA, LLC | 2 | $32 |
| Boston Scientific Corporation | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
Products named: Kerendia, Ozempic, MOUNJARO, Auvelity, VRAYLAR, Rybelsus, Patient Trial Kit, WaveWriter Alpha Prime 16.
Industry payments across MS — which companies pay providers there.
